Skip to main content

Micronutrient status of COVID-19 patients: a critical consideration

As the novel coronavirus (SARS-CoV-2) pandemic continues to grip the world, ongoing research is highlighting the factors associated with higher risk of severe morbidity and mortality. These factors include older age, male, and comorbidities, including obesity [1]. Relatively little attention, however, is paid to the micronutrient status of COVID-19 patients. Micronutrients are vitamins and specific minerals that are critical to the proper structure and functioning of numerous proteins, enzymes, physiological processes, and signaling pathways within the body. Without these micronutrients, these essential processes cease to function properly, and this contributes to morbidity and, in cases of severe deficiency, mortality.

The term “micronutrients” refers to the fact that these nutrients are required in small, usually microgram, amounts daily. However, in critical illness, the requirements for these micronutrients can increase significantly. This is particularly true for vitamin C, which is severely depleted in critically ill patients at admission and is required in gram amounts to replete the patients [2]. Severe respiratory infections, such as pneumonia, are a common complication of severe vitamin C deficiency, and pneumonia is one of the most common causes of mortality in patients with severe vitamin C deficiency [3]. This indicates an important link between vitamin C status and respiratory infections.

Vitamin C has numerous important and pleiotropic roles in immune function, including regulation of hundreds of genes in immune cells [3]. Although the vitamin C status of patients with COVID-19 has not yet been reported in the literature, it is known that the vitamin C status of patients with community-acquired pneumonia is severely depleted and is associated with enhanced oxidative stress [4]. However, it is not yet known if vitamin C deficiency is a cause and/or a consequence of severe infection, as the latter results in enhanced requirements for the vitamin.

There are numerous factors, in addition to inadequate diet, that are associated with depleted vitamin C status [5]; these include male gender, comorbidities, and obesity, which are also associated with enhanced susceptibility to COVID-19. Therefore, it is important to consider that differences in susceptibility to, and severity of, COVID-19 could be partly due to insufficient micronutrient levels for adequate immune and organ function. As such, it would be of benefit to COVID-19 patients if critical care physicians take this into consideration and test for potential micronutrient insufficiencies in their patients and, if indicated, supplement with adequate amounts to restore normal status and function. This may help improve patient outcomes.

Availability of data and materials



  1. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020;24(1):108.

    Article  Google Scholar 

  2. Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21:300.

    Article  Google Scholar 

  3. Carr AC. Vitamin C in pneumonia and sepsis. In: Chen Q, Vissers M, editors. Vitamin C: new biochemical and functional insights. Oxidative stress and disease. Boca Raton: FL CRC Press/Taylor & Francis; 2020. p. 115–35.

    Chapter  Google Scholar 

  4. Carr AC, Spencer E, Dixon L, Chambers ST. Patients with community acquired pneumonia exhibit depleted vitamin C status and elevated oxidative stress. Nutrients. 2020;12(1318):10.

    Google Scholar 

  5. Carr AC, Rowe S. Factors affecting vitamin C status and prevalence of deficiency: a global health perspective. Preprints. 2020;28358.

Download references


ACC is the recipient of a Health Research Council of New Zealand Sir Charles Hercus Health Research Fellowship.



Author information

Authors and Affiliations



ACC wrote the letter. The author read and approved the final manuscript.

Corresponding author

Correspondence to Anitra C. Carr.

Ethics declarations

Ethics approval and consent to participate


Consent for publication


Competing interests


Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carr, A.C. Micronutrient status of COVID-19 patients: a critical consideration. Crit Care 24, 349 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: